SCHEMBL6406569

SCHEMBL6406569

COC(=O)C1CC1COCc1ccc(OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.49
FFAR4 Q5NUL3 2/20 0.47
FABP7 O15540 1/20 0.42
FABP5 Q01469 1/20 0.42
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
HDAC4 P56524 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
POLB P06746 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F2RL1 P55085 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
EPHX2 P34913 1/20 0.41
MMP1 P03956 1/20 0.41
MMP2 P08253 1/20 0.41
MMP3 P08254 1/20 0.41
MMP9 P14780 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409649 0.88 CA1 (0.54) HTTFFAR4FABP7FABP5ALDH1A1
SCHEMBL22340184 0.88 CA1 (0.54) HTTFFAR4FABP7FABP5ALDH1A1
SCHEMBL2186744 0.87 FFAR4 (0.47) HTTFFAR4FABP7FABP5ALDH1A1
SCHEMBL6408927 0.87 FFAR4 (0.58) HTTFFAR4FABP7FABP5HDAC4
SCHEMBL2186749 0.87 FFAR4 (0.47) HTTFFAR4FABP7FABP5ALDH1A1
SCHEMBL6407549 0.87 CPB1 (0.51) FFAR4ALDH1A1POLBCYP3A4CPB1
SCHEMBL17407791 0.87 CPB1 (0.51) FFAR4ALDH1A1POLBCYP3A4CPB1
SCHEMBL6409542 0.87 L3MBTL1 (0.44) HTTFFAR4FABP7FABP5ALDH1A1
SCHEMBL6406962 0.85 FFAR4 (0.49) FFAR4ALDH1A1MAPTPOLBSMN1; SMN2
SCHEMBL6414684 0.84 CACNA1B (0.44) HTTFFAR4ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids SUMITOMO CHEMICAL COMPAY LIMTED (JP) 2005-12-29 US disclosed
EP-1538141-A1 PROCESS FOR PRODUCTION OF 2-(HYDROXYMETHYL)CYCLO- PROPANECARBOXYLIC ACIDS Sumitomo Chemical Company, Limited (JP) 2005-06-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288526-A1 Process for production of 2-(hydroxymethyl)cyclo-propanecarboxylic acids GRHPR, PCCA, C5 HTT 1851/4885FFAR4 2429/4885FABP7 4846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.